Trials / Recruiting
RecruitingNCT07091968
Feasibility of a Technology-Based Intervention for Depression Referral Uptake in Cancer Survivors
Pilot Feasibility Trial to Evaluate a Technology-Enabled Approach to Enhance Depression Referral Uptake Among Cancer Survivors
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Medical University of South Carolina · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Depression is very common in cancer survivors but there are challenges to linking those in need of treatment efficiently to care. In this study, investigators will test the feasibility and acceptability of a new text-based approach to connect cancer survivors with depression with care.
Detailed description
The objectives of this study are 1) to evaluate the feasibility and acceptability of a technology-enabled approach to improve referral uptake among cancer survivors and 2) to evaluate the preliminary efficacy of this approach to improve referral uptake compared to usual care among cancer survivors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Technology-Enabled Tailored Referral | Participants in the intervention arm will receive a technology-enabled, text-based referral platform designed to improve depression referral uptake. The platform includes an initial text with a brief video explaining common barriers, tailored text messages based on participant-identified barriers, and an automated referral link. Messages are mapped to stages of readiness using the Transtheoretical Model and sent every two days over a two-week period to non-responders or decliners. This approach aims to engage survivors with depression through personalized, accessible, and stage-matched communication. |
Timeline
- Start date
- 2026-01-16
- Primary completion
- 2026-06-01
- Completion
- 2026-12-01
- First posted
- 2025-07-29
- Last updated
- 2026-02-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07091968. Inclusion in this directory is not an endorsement.